Forbion

Forbion is a leading global venture capital firm dedicated to impacting the future through strategic investments. With deep expertise in Europe, Forbion invests in innovative biotech companies, managing just over €5 billion across multiple fund strategies. These strategies cover all stages of (bio-) pharmaceutical drug development, ensuring comprehensive support from early-stage ventures to mature enterprises.

Forbion extends its biotech expertise beyond human health to address ‘planetary health’ challenges through its BioEconomy fund strategy. This initiative focuses on companies developing sustainable solutions in food, agriculture, materials, and environmental technologies, reflecting a commitment to both economic and environmental well-being. The primary address for Forbion is Gooimeer 2-35, Naarden, 1411 DC, NL. Additional locations include Maximilianstrasse 36, Munich, Bavaria 80539, DE, and 200 Clarendon St, 22nd Floor, Boston, Massachusetts 02116, US.

Committed to fostering innovation and growth, Forbion continues to drive advancements in bioscience, therapeutics, and healthcare. Forbion’s strategic approach and dedication to sustainable solutions position it as a key player in the venture capital landscape. We invite the manager of Forbion to create a customized and exclusive company showcase and product listing on our platform to further enhance your market presence.